celiac disease

Takeda booth at AACR 2026
Biotech

Takeda scraps another phase 2 celiac disease therapy

Takeda has dropped another celiac disease therapy from its phase 2 pipeline, leaving the company with just one shot at treating the condition.
James Waldron Jul 30, 2026 9:18am
A chessboard with blocks that read MA

Argenx acquires Forte for $2.2B for ph.2-stage vitiligo drug

Jul 27, 2026 6:08am
Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b

Barinthus enters reverse merger with metabolic disease biotech

Sep 30, 2025 10:39am
Healthy foods surrounding chalk drawing of gut

Edited T cells allow gluten-sensitive mice to eat grains

Mar 20, 2025 7:16am
bowel

GI-focused CRO boosts trial tech with adaptive software

Feb 3, 2025 11:40am
An arrow incrementally going up stairs before pointing straight up Blue background

Topas says celiac candidate shines but keeps data under wraps

Oct 15, 2024 8:08am